Abstract

Thrombocytopenia is a frequent finding in intensive care unit especially among adults and medical ICU patients. Thrombocytopenia is defined as a platelet count less than 100×109/l in ICU setting. Platelets are made in the bone marrow from megakaryocytes. Although not fully understood, proplatelets transform into platelets in the lung. The body tries to maintain platelet count relatively constant throughout life. Pathophysiology of thrombocytopenia can be defined by hemodilution, elevated levels of platelet consumption, compromise of platelet production, increased platelet sequestration and increased platelet destruction. Unlike in other situations, absolute platelet count alone does not provide sufficient data in characterizing thrombocytopenia in ICU patients. In such cases, the time course of changes in platelet count is also pivotal. The dynamics of platelet count decrease vary considerably between different ICU patient populations including trauma, major surgery and minor surgery/medical conditions.There are strong evidences available that delay in platelet count restoration in ICU patients is an indicator of a bad outcome.

Highlights

  • Thrombocytopenia is a frequent finding in intensive care unit (ICU), with an incidence ranging from 13% to almost 60% in different studies

  • While many authors believe that the emergence of thrombocytopenia in ICU patients could dramatically increase the risk of morbidity and mortality; others suggest that this thrombocytopenia is only an indicator of another more important underlying cause, such as a critical illness or using a particu

  • Heparin-induced thrombocytopenia (HIT) is caused by the development of IgG antibodies directed against a complex of platelet factor 4 (PF4) and heparin[31] and presenting with more than a half of the baseline platelet count, to 50-80×109/L or a new thrombosis occurring 5-14 days after heparin initiation.[30]

Read more

Summary

Thrombocytopenia in the intensive care unit

Zohreh Ostadi[1], Kamran Shadvar[2], Sarvin Sanaie[3], Ata Mahmoodpoor[4], Seied Hadi Saghaleini[5]

INTRODUCTION
Increased platelet destruction
Thrombocytopenia in ICU
Dipyridamole and ticlopidine
Findings
Definite other cause is present
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call